Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Weiner SD, Liang LW, Masri A, Abraham TP, Barriales-Villa R, Cooper RM, Elliott PM, de Feria A, Maron MS, Oreziak A, Saberi S, Solomon SD, Spertus JA, Tower-Rader A, Butzner M, Godown J, Heitner SB, Jacoby DL, Kupfer S, Liu X, Malik FI, Melloni C, Simkins TJ, Wei J, Nassif ME, Owens AT. Long-term impact of aficamten on patient-reported outcome measures in obstructive hypertrophic cardiomyopathy: results from FOREST-HCM. Eur J Heart Fail. 2026 Oct 28; 28(4):819-830.
-
Evans EA, Stopka TJ, Pivovarova E, Ryan D, Murphy SM, Jaffe K, Bernson D, Bovell-Ammon B, McCollister KE, Bianchet E, Hoskinson R, Friedmann PD. Jail-based opioid treatment implementation, outcomes, and costs: lessons learned from the Massachusetts Justice Community Opioid Innovation Network (MassJCOIN). Harm Reduct J. 2026 10 23; 23(1).
-
Romoli M, Muppa J, Lee EM, Mandel DM, Kam W, Mac Grory B, Zubair AS, ElNazeir M, Frontera JA, Salehi Omran S, Saleh Velez FG, Rothstein A, Khazaal O, Ghannam M, Almajali M, Samaniego EA, Bavarsad Shahripour R, Al Kasab S, Fonseca AC, Heldner MR, Antonenko K, De Marco G, Longoni M, Faini C, Tudisco V, Zedde M, Pascarella R, Marto JP, Sousa JA, Botelho Rosa S, Nunes AP, Aguiar De Sousa D, Nehme A, Shu L, Yaghi S, Henninger N. Recanalization After Acute Cervical Artery Dissection: A Multicenter International Study. Neurology. 2026 Nov 10; 107(9):e218566.
-
Vanamudhu A, Viswanathan V, Mohan G, Krishna Rao N, Thiruvengadam K, Hissar S, Permal Kannabiran B, Babu S, Kornfeld H, Pavan Kumar N. Prognostic utility of immune biomarkers for identifying individuals at risk of unfavourable treatment outcomes in pulmonary tuberculosis. Front Immunol. 2026; 17:1928573.
-
Mian H, Faisal MS, Chen T, Brazauskas R, Oloyede T, Ahmed N, Afrough A, Anderson LD, Banerjee R, Berdeja J, Bidikian A, Devos J, Dhakal B, Dias A, Dima D, Efebera YA, Gowda L, Hansen DK, Hashmi H, Landau HJ, Lekakis L, Mirza AS, Narra R, Patel K, Rosko AE, Schroeder M, Sidana S, Usmani S, Pasquini MC, Nishihori T, Akhtar OS, Mohan M. Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis. Cancer. 2026 Oct 01; 132(19):e70614.
-
Findlay MC, Gandhoke GS, Davies JM, Knopman J, Smith KJ, Mokin M, Hassan AE, Harbaugh RE, Khalessi A, Fiehler J, Gross BA, Tarpley JW, Sivakumar W, Bain M, Crowley RW, Link TW, Fraser JF, Levitt MR, Chen PR, Hanel RA, Bernard JD, Jumaa M, Youssef P, Cress MC, Chaudry MI, Shakir HJ, Lesley WS, Billingsley J, Jones JG, Koch MJ, Paul AR, Mack WJ, Osbun JW, Dlouhy K, Grossberg JA, Kellner CP, Sahlein DH, Santarelli J, Schirmer CM, Liu JJ, Majjhoo AQ, Wolfe T, Patel NV, Roark C, Siddiqui AH, Grandhi R. Cost-Effectiveness of Adjunctive Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Secondary Analysis of EMBOLISE. AJNR Am J Neuroradiol. 2026 Oct 01; 47(10):2500-2509.
-
Wang PJ, Gerstenfeld EP, Piccini JP, Verma A, Bunch TJ, Blomstrom-Lundqvist C, Tzeis S, Andrade JG, Camm AJ, Chen LY, Passman R, Reynolds MR, Calkins H, Russo AM, Jais P, Chung M, Schmidt B, Perez M, Wan EY, Thomas KL, Mihas E, Hills MT, Weiss JP. Atrial Fibrillation Ablation Effectiveness End Points, Safety End Points, and Trial Design: Academic Research Consortium Initiative Endorsed by the Heart Rhythm Society. Circ Arrhythm Electrophysiol. 2026 Oct; 19(10):e015082.
-
Maguire AS, Ta NL, Gross AL, Garrett CJ, Zimmerman AD, Diffie EB, Osterhoudt DE, Pacer SH, Mitchell ML, Cannon JS, Hall PI, Sandey M, Cole RC, Seyfried TN, Gray-Edwards HL, Sena-Esteves M, Martin DR. Intravenous gene therapy improves life span and clinical outcomes in a feline model of Sandhoff disease. Sci Transl Med. 2026 09 09; 18(866):eadx2447.
-
Sciurba FC, Watz H, Bourdin A, Janssens W, Martinez FJ, Zheng J, van den Berge M, Bonini M, Han MK, Singh D, Criner GJ, Brightling CE, Papi A, Bhatt SP, Jenkins M, Mikosz M, Cho?bi?ski P, Ziemiecka M, Löfdahl M, Arya D, Yadavalli M, Brodek BH, Fagerås M, Bardsley S, Martin N, Patel R, Psallidas I. Tozorakimab to Prevent COPD Exacerbations. N Engl J Med. 2026 Oct 29; 395(17):1703-1716.
-
Paganoni S, Chibnik LB, Quintana M, Macklin EA, Detry MA, Vestrucci M, Paulon G, McGlothlin A, Wang J, Walk D, Elman L, Chase M, Heyd L, Harkey B, Sherman AV, Shefner J, Berry JD, Scirocco E, Giacomelli E, Yu H, Kittle G, Hall M, Ho D, Jawdat O, Ladha S, Locatelli E, Rivner M, Felice K, Katz J, Ajroud-Driss S, Fee D, Miller T, Rosow L, Quick A, Heitzman D, Foster LA, Maragakis NJ, Goutman SA, Rosenfeld J, Benatar M, Swenson A, Connors RD, Shroff S, Bedlack R, McIlduff CE, Chen IA, Fernandes JAM, Walsh A, Peltier A, Ilieva H, Diaz F, Kushlaf H, Beydoun SR, Myers B, Arcila-Londono X, Heiman-Patterson T, Elliott M, Whitesell J, Al-Lahham T, Elliott M, Olney N, Baer M, Jackson C, Young E, Caress J, Weiss MD, Kuenzler R, Nayar S, Kasarskis EJ, Simmons Z, Gibson S, Owegi MA, Goyal NA, Wymer JP, Gwathmey KG, Erickson A, Gursoy N, Alameda G, Bodkin C, Wu A, Martinez-Thompson J, Twydell PT, Andrews J, Bayat E, Rezania K, Usman U, McCluskey L, Kovvuru S, Jennings D, Garza-Meilandt A, Maciuca R, Cohen IV, Tamuly D, Eren E, Cudkowicz ME, Babu S. DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Netw Open. 2026 Sep 01; 9(9):e2634809.